Cemiplimab plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer with PD-L1≥1%: 5‑year update of EMPOWER-Lung 3 results

20260 citationsJournal Article

Authors

Good health and well-being

Published in: Pneumologie

Volume 80, Issue S 01, pp. S59-S60

Field-Weighted Citation Impact: 0.00